(Q77905226)
Statements
Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure (English)
Zhang X
Recchia FA
Bernstein R
Xu X
Nasjletti A
1 February 1999